Sector Chart Astellas Pharma Inc.

4503

JP3942400007

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Pharmaceuticals

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
ASTELLAS PHARMA INC.	26.72B
ELI LILLY AND COMPANY	1,116B
JOHNSON & JOHNSON	610B
ABBVIE INC.	501B
MERCK & CO., INC.	358B
ROCHE HOLDING AG	366B

Delayed Japan Exchange 02:08:46 2026-10-16 EDT			5-day change	1st Jan Change
2,421.50 ^JPY	+2.76%		+7.70%	+15.65%

10-08	Vir Biotechnology's VIR-5500 Gets FDA Fast Track Designation for Prostate Cancer	MT
10-08	Vir Biotechnology, Inc. and Astellas Pharma Inc. Announce FDAFast Track Designation for PSMA-Targeted Pro-XTEN® Dual-Masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer	CI

Sector Chart Astellas Pharma Inc.

Stocks

4503

JP3942400007

Pharmaceuticals

Sector Other Pharmaceuticals